Most American adults are not routinely screened or assessed for dementia until symptoms are apparent or readily recognizable. A wide array of innovations are now emerging that can enable dementia screening and assessment more rapidly, comprehensively, and at greater scale than typically seen today. Innovative tests, tools, and protocols are also creating capabilities to detect dementia at an early and even pre-symptomatic stage.

Join Tom Hubbard, Senior Vice President of Policy Research at NEHI, as he covers:

• What are these innovations?
• Could they usher in a new era of dementia screening in primary care, in community settings or the home?
• What does the arrival of these innovations mean for clinical practice and health care policy?

We are honored to include an expert panel of speakers in our discussions: 

• Elli Kaplan, MBA, Cofounder & CEO of Neurotrack
• Vijaya Kolachalama, PhD, FAHA, Associate Professor, Boston University School of Medicine
• Jennifer Pollack, JD, Director of Access Policy, Alzheimer's Association and Alzheimer's Impact Movement
• Claire Sexton, DPhil, Senior Director of Scientific Programs & Outreach, Alzheimer's Association

To preview the discussion, we recommend reading NEHI's recent report, "Detecting Dementia: Emerging Innovations and Their Implications for American Adults and Their Health Care." Attendees may also be interested in reading NEHI's previous report, "Diagnosing Hope: The New Era of Alzheimer's Disease Treatment Hinges on Innovations in Diagnostics," published in October, 2023.